Class Action Firm Monteverde Investigates Mergers Involving CARM, GNTY, TSBX, and SAGE
Shareholder Alert: Mergers Under Investigation
In a significant update for shareholders, Monteverde & Associates PC, known for its successful track record in class action lawsuits, is currently investigating several noteworthy mergers. The firm, which has recovered millions for investors, is renowned for focusing on cases that promise outcomes beneficial to shareholders.
Recent Mergers Under Review
1. Carisma Therapeutics Inc. (NASDAQ: CARM) recently announced its intent to merge with OrthoCellix, Inc. Following the transaction's completion, existing shareholders of Carisma are projected to retain a stake of approximately 10% in the new entity. For more detailed information about this case, shareholders can access resources at Monteverde Law.
2. Guaranty Bancshares, Inc. (NYSE: GNTY) is another targeted case as it moves towards a merger with Glacier Bancorp, Inc. In this instance, shareholders of Guaranty Bancshares will receive one share of Glacier common stock for each share held in Guaranty, although this may be subject to certain adjustments. More on this case can be found at Monteverde Law.
3. Turnstone Biologics Corp. (NASDAQ: TSBX) is also undergoing scrutiny as it prepares for a merger with XOMA Royalty Corporation. Current Turnstone shareholders are in line to receive $0.34 in cash per share along with a non-transferable contingent value right. More details regarding this case are available at Monteverde Law.
4. Sage Therapeutics, Inc. (NASDAQ: SAGE) interacts with its merger with Supernus Pharmaceuticals, Inc. If successful, shareholders will obtain $8.50 per share in cash, plus a non-tradable contingent value right potentially valued up to $3.50 per share, contingent upon specific future sales milestones. For further details, shareholders are encouraged to visit Monteverde Law.
About Monteverde & Associates PC
Juan Monteverde, leading the charge at his firm, prides himself on providing robust legal representation to investors in class action securities lawsuits. The firm is located at the iconic Empire State Building in New York City and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. Monteverde & Associates has a strong reputation for its vigorous approach in the courts and has proven its expertise in navigating complex shareholder issues.
Why It Matters
For shareholders of CARM, GNTY, TSBX, and SAGE, staying informed about these mergers is critical, as they could impact ownership stakes and financial outcomes significantly. With the backdrop of ongoing mergers within these companies, current investors should leverage the insights provided by Monteverde. By being proactive and engaged, shareholders can position themselves to safeguard their investments and potentially benefit from the firm’s findings.
Legal Contact Information
For those interested in understanding their rights as shareholders or pursuing further information, Monteverde & Associates encourages contact via email at [email protected] or by telephone at (212) 971-1341. Shareholders are assured that there is no financial obligation to learn more about these investigations.
With a legacy of success and a dedicated focus on shareholder rights, Monteverde & Associates PC is at the forefront of protecting what matters most to investors.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.